We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Roche Enters Strategic Alliance with Technoclone to Expand Reagent Portfolio for Coagulation Diagnostics Line Targeted for US and Canada in 2014

News   Feb 01, 2012

 
Roche Enters Strategic Alliance with Technoclone to Expand Reagent Portfolio for Coagulation Diagnostics Line Targeted for US and Canada in 2014
 
 
Advertisement
 

RELATED ARTICLES

Blood Markers of Fitness Identified

News

A simple blood test may be able to determine how physically fit you are, according to a new study conducted by scientists at the Stanford University School of Medicine.

READ MORE

Markers in Blood Can Help Identify Risk for Complications After Mild TBI

News

Molecules released into the blood following mild traumatic brain injury may be indicators of neuronal damage associated with complications, according to new research.

READ MORE

Could Sugars Be the Key to a “Better” Test for Prostate Cancer

News

A new type of test that uses complex sugars to detect prostate cancer, earlier and more accurately, is being developed by researchers at the University of Birmingham.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE